NLRP3 and type 2 diabetes mellitus: Oridonin has been reported to be an effective anti‐inflammatory molecule in the treatment of gouty arthritis, type 2 diabetes, and peritonitis and it functions by inhibiting NLRP3 activation (He et al., 2018).